Posts Tagged 'statins'

Study Suggests Lipitor-Diabetes Risk Higher For Women

Lipitor, an anti-cholesterol drug manufactured by Pfizer, has been under fire for allegations that it increases the risk of women developing diabetes. The drug, which belongs to the class of cholesterol-lowering medications called statins, has been linked by numerous researchers to higher rates of diabetes.

In 2010, an epidemiological analysis of 13 statin trials recognized that statins significantly increase the risk for diabetes. The authors analyzed data from ...

continue reading...

Diet changes an option for Lipitor users

An ABC News report asks the question of whether America is an “overmedicated nation,” and offers alternatives to some of the most commonly prescribed medications.

Among those medications are the anti-cholesterol drugs known as statins. According to the report, the pharmacies fill more than 45 million prescriptions a year for the statin known as Lipitor alone.

But recent research indicates that statins may carry some health risks. The U.S. Food and Drug ...

continue reading...

Pfizer selling Irish manufacturing factory

A story in the Irish Independent says Pfizer intends to sell one of its Irish plants, in large part because of declining revenues from its anti-cholesterol drug Lipitor.

Sales of Lipitor, a former blockbuster for the company, have been plummeting recently because its patent expired, opening it up to competition from generics. The drug has also been the subject of some recent health concerns.

The U.S. Food and Drug Administration has added ...

continue reading...

EU Doctors urge caution when prescribing Lipitor

Some European medical professionals are urging their colleagues to use caution in prescribing the class of cholesterol-lowering drugs known as statins, following reports linking the medications to a higher risk of diabetes.

In a study published in the British Medical Journal, Canadian researchers said powerful statins such as Lipitor may increase the risk of Type 2 diabetes by 22 percent compared with weaker drugs. The researchers analyzed a sample of 1.5 ...

continue reading...

Writer’s reluctance to take Lipitor led to effective diet

In an interview with the Huffington Post, New York Times food writer Mark Bittman discusses his new diet plan that consists of eating vegan, or eating no animal products, before 6 p.m. every day. Bittman has recently published a book on his diet called VB6: Eat Vegan Before 6:00 to Lose Weight and Restore Your Health … for Good.

In the book, Bittman writes that at the age of 57, he ...

continue reading...

Liptruzet cholesterol medication’s approval is controversial

In a piece for Forbes, writer John LaMattina takes issue with Merck’s attempts to get the LDL cholesterol lowering drug, Liptruzet, approved and on the market. He also finds fault with the U.S. Food and Drug Administration for approving it in the first place.

LaMattina writes that Liptruzet is really a combination of two drugs that are already on the market – Merck’s own Zetia and Pzizer’s Lipitor.

Despite the U.S. Food ...

continue reading...
Page 2 of 6 12345...»